Activated partial thromboplastin time following Kcentra® versus Balfaxar® reversal of apixaban, rivaroxaban, and warfarin: a propensity-matched cohort study

American Journal of Emergency Medicine · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles